Sciencast Management’s Elevance Health ELV Stock Holding History

Sciencast Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,248	Closed	-$3.04M	–	275
2024 Q4	$3.04M	Buy	+8,248	New	+$3.45M	0.83%	20
2023 Q4	–	Sell	-1,429	Closed	-$622K	–	279
2023 Q3	$622K	Buy	+1,429	New	+$648K	0.28%	138
2022 Q2	–	Sell	-4,447	Closed	-$2.21M	–	462
2022 Q1	$2.21M	Buy	+4,447	New	+$2.03M	0.51%	61
2021 Q4	–	Sell	-1,000	Closed	-$370K	–	503
2021 Q3	$370K	Buy	+1,000	New	+$380K	0.1%	260
2021 Q2	–	Sell	-3,524	Closed	-$1.25M	–	530
2021 Q1	$1.25M	Buy	+3,524	New	+$1.13M	0.25%	128
2020 Q2	–	Sell	-3,075	Closed	-$635K	–	429
2020 Q1	$635K	Buy	+3,075	New	+$838K	0.18%	83
2019 Q2	–	Sell	-8,750	Closed	-$2.53M	–	333
2019 Q1	$2.53M	Buy	+8,750	New	+$2.53M	0.9%	6
2018 Q4	–	Sell	-900	Closed	-$244K	–	261
2018 Q3	$244K	Buy	+900	New	+$234K	0.16%	217
2018 Q2	–	Sell	-1,469	Closed	-$337K	–	289
2018 Q1	$337K	Sell	1,469 -237	-14%	-$55.7K	0.17%	221
2017 Q4	$427K	Buy	1,706 +117	+7%	+$24.9K	0.23%	176
2017 Q3	$335K	Sell	1,589 -165	-9%	-$31.4K	0.19%	194
2017 Q2	$330K	Buy	+1,754	New	+$315K	0.18%	212

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Sciencast Management's ELV Position: Q1 2025 in Review

Sciencast Management sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 8,248 shares — an estimated $3.04M sold.

Sciencast Management first reported a position in ELV in Q2 2017 and held it in 12 quarters. The position peaked at $3.04M in Q4 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

Sciencast Management reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
Sciencast Management sold 8,248 Elevance Health shares in Q1 2025, an estimated $3.04M.
Sciencast Management first reported a position in Elevance Health in Q2 2017 and held it in 12 quarters.
Sciencast Management's Elevance Health position peaked at $3.04M in Q4 2024.
1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Sciencast Management's 13F filing for Q1 2025, filed 16 May 2025.